We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Moderate to strong cytoplasmic immunoreactivity was found in most malignant lymphomas, melanomas and stomach cancers. Positivity was seen in squamous cell carcinomas of skin, while most basal cell carcinomas were negative.
GO:0002481 [antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent] GO:0002485 [antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent] GO:0002489 [antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent] GO:0002504 [antigen processing and presentation of peptide or polysaccharide antigen via MHC class II] GO:0002591 [positive regulation of antigen processing and presentation of peptide antigen via MHC class I] GO:0005515 [protein binding] GO:0005524 [ATP binding] GO:0006810 [transport] GO:0006955 [immune response] GO:0008152 [metabolic process] GO:0015197 [peptide transporter activity] GO:0015440 [peptide-transporting ATPase activity] GO:0015833 [peptide transport] GO:0016020 [membrane] GO:0016021 [integral component of membrane] GO:0016887 [ATPase activity] GO:0019882 [antigen processing and presentation] GO:0042287 [MHC protein binding] GO:0042613 [MHC class II protein complex] GO:0042626 [ATPase activity, coupled to transmembrane movement of substances] GO:0042825 [TAP complex] GO:0055085 [transmembrane transport]
